- Home
- PRTA vs BAND Comparison
PRTA vs BAND Comparison
Compare PRTA & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- BAND
- Stock Information
- Founded
- PRTA 2012
- BAND 2000
- Country
- PRTA Ireland
- BAND United States
- Employees
- PRTA N/A
- BAND N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- BAND Computer Software: Prepackaged Software
- Sector
- PRTA Health Care
- BAND Technology
- Exchange
- PRTA Nasdaq
- BAND Nasdaq
- Market Cap
- PRTA 472.1M
- BAND 431.0M
- IPO Year
- PRTA N/A
- BAND 2017
- Fundamental
- Price
- PRTA $8.20
- BAND $15.00
- Analyst Decision
- PRTA Buy
- BAND Buy
- Analyst Count
- PRTA 10
- BAND 6
- Target Price
- PRTA $14.86
- BAND $20.80
- AVG Volume (30 Days)
- PRTA 1.2M
- BAND 190.8K
- Earning Date
- PRTA 08-04-2025
- BAND 10-30-2025
- Dividend Yield
- PRTA N/A
- BAND N/A
- EPS Growth
- PRTA N/A
- BAND N/A
- EPS
- PRTA N/A
- BAND N/A
- Revenue
- PRTA $10,341,000.00
- BAND $758,106,000.00
- Revenue This Year
- PRTA N/A
- BAND $2.48
- Revenue Next Year
- PRTA $389.77
- BAND $13.24
- P/E Ratio
- PRTA N/A
- BAND N/A
- Revenue Growth
- PRTA N/A
- BAND 14.51
- 52 Week Low
- PRTA $4.32
- BAND $11.33
- 52 Week High
- PRTA $22.83
- BAND $23.00
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- BAND 56.17
- Support Level
- PRTA $8.05
- BAND $14.21
- Resistance Level
- PRTA $8.73
- BAND $14.84
- Average True Range (ATR)
- PRTA 0.38
- BAND 0.49
- MACD
- PRTA -0.05
- BAND 0.15
- Stochastic Oscillator
- PRTA 47.62
- BAND 90.04
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.